These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 14667889

  • 41. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
    Martel C, Labrie F, Archer DF, Ke Y, Gonthier R, Simard JN, Lavoie L, Vaillancourt M, Montesino M, Balser J, Moyneur É, other participating members of the Prasterone Clinical Research Group.
    J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
    [Abstract] [Full Text] [Related]

  • 42. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
    Milewicz T, Krzysiek J, Janczak-Saif A, Sztefko K, Krzyczkowska-Sendrakowska M.
    Endokrynol Pol; 2005 May; 56(6):883-90. PubMed ID: 16821206
    [Abstract] [Full Text] [Related]

  • 43. Oral dehydroepiandrosterone restores ß-endorphin response to OGTT in early and late postmenopause.
    Giannini A, Genazzani AD, Napolitano A, Caretto M, Stomati M, Simoncini T, Genazzani AR.
    Gynecol Endocrinol; 2019 Sep; 35(9):767-771. PubMed ID: 30935252
    [Abstract] [Full Text] [Related]

  • 44. Cytokine pattern in postmenopause.
    Cioffi M, Esposito K, Vietri MT, Gazzerro P, D'Auria A, Ardovino I, Puca GA, Molinari AM.
    Maturitas; 2002 Mar 25; 41(3):187-92. PubMed ID: 11886764
    [Abstract] [Full Text] [Related]

  • 45. Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study.
    Caufriez A, Leproult R, L'Hermite-Balériaux M, Kerkhofs M, Copinschi G.
    Clin Endocrinol (Oxf); 2013 Nov 25; 79(5):716-24. PubMed ID: 23488643
    [Abstract] [Full Text] [Related]

  • 46. Changes in reproductive hormones and sex hormone-binding globulin in a group of postmenopausal women measured over 10 years.
    Jiroutek MR, Chen MH, Johnston CC, Longcope C.
    Menopause; 1998 Nov 25; 5(2):90-4. PubMed ID: 9689202
    [Abstract] [Full Text] [Related]

  • 47. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function.
    Valtysdóttir ST, Wide L, Hällgren R.
    J Rheumatol; 2001 Jun 25; 28(6):1259-65. PubMed ID: 11409117
    [Abstract] [Full Text] [Related]

  • 48. Dhea supplementation and cognition in postmenopausal women.
    Parsons TD, Kratz KM, Thompson E, Stanczyk FZ, Buckwalter JG.
    Int J Neurosci; 2006 Feb 25; 116(2):141-55. PubMed ID: 16393880
    [Abstract] [Full Text] [Related]

  • 49. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women.
    Bernardi F, Pieri M, Stomati M, Luisi S, Palumbo M, Pluchino N, Ceccarelli C, Genazzani AR.
    Gynecol Endocrinol; 2003 Feb 25; 17(1):65-77. PubMed ID: 12724021
    [Abstract] [Full Text] [Related]

  • 50. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women.
    Mortola JF, Yen SS.
    J Clin Endocrinol Metab; 1990 Sep 25; 71(3):696-704. PubMed ID: 2144295
    [Abstract] [Full Text] [Related]

  • 51. Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients.
    Lønning PE, Johannessen DC, Lien EA, Ekse D, Fotsis T, Adlercreutz H.
    J Steroid Biochem Mol Biol; 1995 May 25; 52(5):491-6. PubMed ID: 7748814
    [Abstract] [Full Text] [Related]

  • 52. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
    Morales AJ, Nolan JJ, Nelson JC, Yen SS.
    J Clin Endocrinol Metab; 1994 Jun 25; 78(6):1360-7. PubMed ID: 7515387
    [Abstract] [Full Text] [Related]

  • 53. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiébaut A, González CA, Quirós JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E.
    Endocr Relat Cancer; 2005 Dec 25; 12(4):1071-82. PubMed ID: 16322344
    [Abstract] [Full Text] [Related]

  • 54. Puberty in boys: correlation of plasma levels of gonadotropins (LH, FSH), androgens (testosterone, androstenedione, dehydroepiandrosterone and its sulfate), estrogens (estrone and estradiol) and progestins (progesterone and 17-hydroxyprogesterone).
    Lee PA, Migeon CJ.
    J Clin Endocrinol Metab; 1975 Sep 25; 41(3):556-62. PubMed ID: 125762
    [Abstract] [Full Text] [Related]

  • 55. The role of androgens in the late-premenopausal woman with adenomatous hyperplasia of the endometrium.
    Vitoratos N, Gregoriou O, Hassiakos D, Zourlas PA.
    Int J Gynaecol Obstet; 1991 Feb 25; 34(2):157-61. PubMed ID: 1671371
    [Abstract] [Full Text] [Related]

  • 56. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
    Johannsson G, Burman P, Wirén L, Engström BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA.
    J Clin Endocrinol Metab; 2002 May 25; 87(5):2046-52. PubMed ID: 11994339
    [Abstract] [Full Text] [Related]

  • 57. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W, Justl HG, Callies F, Reincke M, Hübler D, Oettel M, Ernst M, Schulte HM, Allolio B.
    J Clin Endocrinol Metab; 1998 Jun 25; 83(6):1928-34. PubMed ID: 9626121
    [Abstract] [Full Text] [Related]

  • 58. Time-related changes in the plasma concentrations of prolactin, gonadotropins, sex hormone-binding globulin, and certain steroid hormones in female runners after a long-distance race.
    Mathur RS, Neff MR, Landgrebe SC, Moody LO, Kirk RF, Gadsden RH, Rust PF.
    Fertil Steril; 1986 Dec 25; 46(6):1067-70. PubMed ID: 2946606
    [Abstract] [Full Text] [Related]

  • 59. Adrenal function under long-term raloxifene administration.
    Genazzani AR, Lombardi I, Borgioli G, di Bono I, Casarosa E, Gambacciani M, Palumbo M, Genazzani AD, Luisi M.
    Gynecol Endocrinol; 2003 Apr 25; 17(2):159-68. PubMed ID: 12737677
    [Abstract] [Full Text] [Related]

  • 60. Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization.
    Keane KN, Hinchliffe PM, Namdar N, Conceicao JL, Newsholme P, Yovich JL.
    Drug Des Devel Ther; 2015 Apr 25; 9():5569-78. PubMed ID: 26487801
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.